159 related articles for article (PubMed ID: 36445193)
1. Validation of transcriptome signature reversion for drug repurposing in oncology.
Koudijs KKM; Böhringer S; Guchelaar HJ
Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36445193
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome Signature Reversion as a Method to Reposition Drugs Against Cancer for Precision Oncology.
Koudijs KKM; Terwisscha van Scheltinga AGT; Böhringer S; Schimmel KJM; Guchelaar HJ
Cancer J; 2019; 25(2):116-120. PubMed ID: 30896533
[TBL] [Abstract][Full Text] [Related]
3. Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates.
Fisher JL; Wilk EJ; Oza VH; Gary SE; Howton TC; Flanary VL; Clark AD; Hjelmeland AB; Lasseigne BN
FEBS Open Bio; 2024 May; 14(5):803-830. PubMed ID: 38531616
[TBL] [Abstract][Full Text] [Related]
4. Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures.
Lee H; Kang S; Kim W
PLoS One; 2016; 11(3):e0150460. PubMed ID: 26954019
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
Front Immunol; 2019; 10():60. PubMed ID: 30761132
[TBL] [Abstract][Full Text] [Related]
6. A novel computational approach for drug repurposing using systems biology.
Peyvandipour A; Saberian N; Shafi A; Donato M; Draghici S
Bioinformatics; 2018 Aug; 34(16):2817-2825. PubMed ID: 29534151
[TBL] [Abstract][Full Text] [Related]
7. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
8. Integrating LINCS Data to Evaluate Cancer Transcriptome Modifying Potential of Small-molecule Compounds for Drug Repositioning.
Zhao Y; Liu Y; Bai H
Comb Chem High Throughput Screen; 2021; 24(9):1340-1350. PubMed ID: 33109034
[TBL] [Abstract][Full Text] [Related]
9. Can Drug Repurposing Accelerate Precision Oncology?
Schipper LJ; Zeverijn LJ; Garnett MJ; Voest EE
Cancer Discov; 2022 Jul; 12(7):1634-1641. PubMed ID: 35642948
[TBL] [Abstract][Full Text] [Related]
10. Human Protein Complex-Based Drug Signatures for Personalized Cancer Medicine.
Wang F; Ding Y; Lei X; Liao B; Wu FX
IEEE J Biomed Health Inform; 2021 Nov; 25(11):4079-4088. PubMed ID: 34665747
[TBL] [Abstract][Full Text] [Related]
11. Identifying Gene Signatures for Cancer Drug Repositioning Based on Sample Clustering.
Wang F; Ding Y; Lei X; Liao B; Wu FX
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(2):953-965. PubMed ID: 32845842
[TBL] [Abstract][Full Text] [Related]
12. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
Zhao K; So HC
Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
[TBL] [Abstract][Full Text] [Related]
13. Nardosinone and aurantio-obtusin, two medicine food homology natural compounds, are anti-influenza agents as indicated by transcriptome signature reversion.
Chen S; Xin Y; Tang K; Wu Y; Guo Y
Phytomedicine; 2023 Jan; 108():154515. PubMed ID: 36347176
[TBL] [Abstract][Full Text] [Related]
14. An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer Metastatization.
Torricelli F; Sauta E; Manicardi V; Mandato VD; Palicelli A; Ciarrocchi A; Manzotti G
Cells; 2023 Mar; 12(5):. PubMed ID: 36899930
[TBL] [Abstract][Full Text] [Related]
15. Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications.
He H; Duo H; Hao Y; Zhang X; Zhou X; Zeng Y; Li Y; Li B
Comput Biol Med; 2023 Mar; 155():106671. PubMed ID: 36805225
[TBL] [Abstract][Full Text] [Related]
16. Drug repurposing for Basal breast cancer subpopulations using modular network signatures.
Coria-Rodríguez H; Ochoa S; de Anda-Jáuregui G; Hernández-Lemus E
Comput Biol Chem; 2023 Aug; 105():107902. PubMed ID: 37348299
[TBL] [Abstract][Full Text] [Related]
17. Accurate Drug Repositioning through Non-tissue-Specific Core Signatures from Cancer Transcriptomes.
Xu C; Ai D; Shi D; Suo S; Chen X; Yan Y; Cao Y; Zhang R; Sun N; Chen W; McDermott J; Zhang S; Zeng Y; Han JJ
Cell Rep; 2018 Oct; 25(2):523-535.e5. PubMed ID: 30304690
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
19. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
Zador Z; King AT; Geifman N
PLoS One; 2018; 13(3):e0194701. PubMed ID: 29558515
[TBL] [Abstract][Full Text] [Related]
20. A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures.
Mokou M; Narayanasamy S; Stroggilos R; Balaur IA; Vlahou A; Mischak H; Frantzi M
Methods Mol Biol; 2023; 2684():59-99. PubMed ID: 37410228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
